Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Frequently asked questions
What sector does Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) operate in?
Zhengye Biotechnology Holding Limited Ordinary Shares belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) current stock price?
As of the latest data, Zhengye Biotechnology Holding Limited Ordinary Shares stock price is $1.42, with a previous close of $1.50. Zhengye Biotechnology Holding Limited Ordinary Shares lost -$0.08 in the last trading session, representing a -5.33% loss.
What is Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) current market capitalization?
Zhengye Biotechnology Holding Limited Ordinary Shares market cap is approximately 67.30 million.
What is Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) Earnings Per Share (EPS)?
The trailing EPS is -$0.20.
Does Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) pay dividends?
No. Zhengye Biotechnology Holding Limited Ordinary Shares does not pay a dividend.
What is Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) beta (volatility) score?
Zhengye Biotechnology Holding Limited Ordinary Shares has a beta of 1.489, suggesting it is more volatile than the market.
